Oral Digoxin Dosing for Rate Control in Atrial Fibrillation
For most adults with atrial fibrillation requiring rate control, start with oral digoxin 0.125 mg once daily; use 0.25 mg daily only in younger patients (<70 years) with normal renal function, and reduce to 0.0625 mg daily in elderly patients, those with renal impairment (CrCl <30 mL/min), or patients on amiodarone.
Digoxin's Role in AF Rate Control
Digoxin is not a first-line agent for rate control in AF. Beta-blockers or non-dihydropyridine calcium channel blockers (diltiazem, verapamil) are preferred as initial monotherapy 1, 2, 3. However, digoxin has specific indications:
When to Use Digoxin:
- Patients with heart failure and reduced ejection fraction (LVEF ≤40%) - digoxin is Class I recommendation 4, 3, 5
- Sedentary or elderly patients where rate control at rest is the primary goal 1
- As adjunctive therapy when beta-blockers or calcium channel blockers alone provide inadequate rate control 1
Critical Limitation:
Digoxin controls heart rate only at rest, NOT during exercise or activity 1, 2. It should not be used as sole therapy in active patients or those with paroxysmal AF 1.
Specific Dosing Recommendations
Standard Adult Dosing (FDA-Approved):
Initial/Maintenance Dose:
- 0.25 mg once daily: Patients <70 years with normal renal function 6
- 0.125 mg once daily: Patients >70 years OR any degree of renal impairment 6
- 0.0625 mg once daily: Marked renal impairment (CrCl <30 mL/min) 6
Dose Adjustments Based on Renal Function:
The FDA label provides weight and creatinine clearance-based dosing 6:
- CrCl ≥60 mL/min: 187.5-250 mcg daily (depending on weight)
- CrCl 40-60 mL/min: 125-187.5 mcg daily
- CrCl 20-40 mL/min: 125 mcg daily
- CrCl 10-20 mL/min: 62.5-125 mcg daily
- CrCl <10 mL/min: 62.5 mcg daily
Recent research confirms that 0.125 mg daily is appropriate for most Japanese patients with AF and heart failure, with dose reduction to 0.0625 mg for those with CrCl <30 mL/min or concurrent amiodarone use 7.
Loading Doses: Generally NOT Recommended
Loading doses are NOT necessary for chronic rate control in stable AF patients 6, 8. The 2006 ACC/AHA/ESC guidelines and FDA label both indicate that gradual digitalization with maintenance dosing is preferred for outpatient management 1, 6.
If rapid digitalization is deemed necessary (uncommon in stable AF):
- Initial dose: 500-750 mcg (0.5-0.75 mg)
- Additional doses: 125-375 mcg at 6-8 hour intervals
- Total loading dose: 750-1250 mcg over 24 hours 6
However, IV digoxin is preferred for acute rate control in hemodynamically unstable patients with AF and heart failure 1.
Target Serum Digoxin Concentration
Target trough level: 0.5-0.9 ng/mL 4, 9
- Levels >1.2 ng/mL associated with increased mortality 10
- Toxic levels typically >2 ng/mL 3
- Check levels 6-8 hours post-dose at steady state (5-7 days with normal renal function, longer with impairment) 6
Recent data from the DIG trial showed mean concentrations of approximately 1.0 ng/mL with standard dosing, but lower targets (<0.9 ng/mL) are now recommended based on safety data 6, 7.
Critical Drug Interactions Requiring Dose Reduction
Reduce digoxin dose by 50% when starting:
Monitoring Requirements
- Baseline: Renal function (creatinine clearance), electrolytes (K+, Mg2+), ECG 4, 10
- Ongoing: Serial monitoring of electrolytes and renal function is mandatory 4
- Serum levels: Not routinely necessary unless toxicity suspected, drug interactions present, or renal function changes 6, 8
Common Pitfalls to Avoid
- Do not use digoxin as monotherapy in active/younger patients - it fails to control rate during exercise 1, 2, 11
- Do not use 0.25 mg daily in elderly patients - high risk of supratherapeutic levels 6, 7
- Do not forget to adjust for renal function - digoxin is renally eliminated 6, 12
- Do not use in pre-excitation syndromes (WPW) - can paradoxically accelerate ventricular response 1
- Do not combine with amiodarone without dose reduction - significantly increases digoxin levels 7, 8
Combination Therapy
When digoxin alone provides inadequate rate control, combination with a beta-blocker or calcium channel blocker is reasonable (Class IIa) 1. The combination of digoxin plus atenolol showed the most effective rate control in comparative studies 11. However, monitor carefully for bradycardia and adjust doses to avoid excessive AV nodal blockade 1.